display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
multiple myeloma - 2nd line (L2)metastatic/advanced OC (mOC) - maintenance (M)
ovarian cancer (OC)metastatic/advanced OC (mOC) - maintenance (M)
rucaparib ARIEL3 ARIEL4 ATHENA-COMBO ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons